Pancreatic Cancer Research

ResearcherNew York Medical CollegeActive in the last 2 years

Deepak Sherpally

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3330-2721; OpenAlex author ID A5091980162. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

  1. Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights. Co-author DOI 10.3389/fonc.2025.1544928↗
  2. Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell Therapies. Co-author DOI 10.3390/cancers17040589↗
  3. Serum MUC5AC Predicts Recurrence in Pancreatic Ductal Adenocarcinoma Patients on Neoadjuvant Chemotherapy Co-author DOI 10.20944/preprints202409.0945.v1↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ashish Manne · 3 shared papers, 2024–2025 · strength 0.90
  2. Upender Manne Manne · 2 shared papers, 2024–2025 · strength 0.36
  3. Kannan Thanikachalam · 2 shared papers, 2024–2025 · strength 0.36
  4. Ashwini Kumar Esnakula · 2 shared papers, 2024–2025 · strength 0.36
  5. Wancai Yang · 2 shared papers, 2024–2025 · strength 0.36
  6. Lianbo Yu · 2 shared papers, 2024–2025 · strength 0.36
  7. Ankur Sheel · 2 shared papers, 2024–2025 · strength 0.36
  8. Jordan M. Cloyd · 2 shared papers, 2024–2025 · strength 0.36
  9. Anup Kasi · 2 shared papers, 2024–2025 · strength 0.36
  10. Ravi Kumar Paluri · 2 shared papers, 2024–2025 · strength 0.36
  11. Timothy Michael Pawlik · 1 shared paper, 2025 · strength 0.21
  12. Sameek Roychowdhury · 1 shared paper, 2024 · strength 0.15
  13. Mary E. Dillhoff · 1 shared paper, 2024 · strength 0.15
  14. Anne M. Noonan · 1 shared paper, 2024 · strength 0.15
  15. Aslam M. Ejaz · 1 shared paper, 2024 · strength 0.15
  16. Shafia Rahman · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.